IRSA Investments Holds On To 8% Gain Near Bell After Morgan Stanley Begins Coverage at Overweight

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo

IRSA Investments Holds On To 8% Gain Near Bell After Morgan Stanley Begins Coverage at Overweight.

Teva Pharmaceutical Requests Stop to Copaxone Patents Expiration Ruling; Shares Down 1.5%

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo

Teva Pharmaceutical Requests Stop to Copaxone Patents Expiration Ruling; Shares Down 1.5%

Dunkin’ Brands Lost Value After Recent Barron’s Article

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo

Dunkin’ Brands Lost Value After Recent Barron’s Article

Silicon Motion Technology was down 2.3%

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo

Silicon Motion Technology’s (SIMO) expects an increase in its total revenue forr Q1.